AllianceRx Walgreens Prime, one of the largest specialty and home delivery pharmacies in the country, recently announced its intent to rebrand.
Effective June 24, 2022, AllianceRx Walgreens Prime will become AllianceRx Walgreens Pharmacy. Walgreens announced full ownership of AllianceRx Walgreens Prime in January, necessitating the name change.
Walgreens Boots Alliance (WBA) recently announced its new corporate consumer-centric healthcare strategy to drive sustainable, long-term profitable growth.
WBA has distilled its strategy into four priorities, all of which work together toward one central aim to deliver advantage growth and community healthcare, while transforming the company’s core business.
- Transform and align the core businesses.
- Build a range of consumer-centric healthcare solutions, which will form the engine for the company’s next phase of growth.
- Refocus the company’s portfolio of business interests.
- Build a high performance culture and a winning diverse team within the company.
Walgreens cares for 35 million chronic patients, contributing 84% of its revenues and plans to do more to help these patients have better outcomes. The recently announced changes at the soon to become AllianceRx Walgreens Pharmacy will play a key role in this objective.
Additionally, Walgreens has identified that 75% of all specialty pharmacy prescriptions originate in health systems. The company’s recent investment in Shields Rx extends its leadership position as a specialty pharmacy integrator to complement the existing onsite community and central fill assets and will create ongoing synergies.
Additional AllianceRx changes include the promotion of senior vice president Tracey James, RPh, to chief operating officer. James, a licensed pharmacist who has been with the organization since its inception, will oversee pharmaceutical and payer relations, clinical and professional services, and Specialty360 therapy teams.
Specialty360 therapy team members will continue to specialize in therapies to better serve patients. New, dedicated therapy directors will work cross-functionally with pharmacy functions to oversee the delivery of patient care.
Team members, including pharmacists, pharmacy technicians, nurses and dietitians, will be certified in specific diagnoses along with associated therapies. Those diagnoses include behavioral health, bone health, chronic inflammatory disease, endocrine, neurology, nursing and infusion-supporting therapies, oncology, organ/infectious disease, pulmonary and allergy, and reproductive health.
Takeaway: AllianceRx’s business model is evolving to meet the needs of patients with chronic diseases